Sector#Biotechnology - Therapeutics
Rejuvenate Biomed is a Belgian based biomedical company engaged in developing prescription drugs in healthy ageing.
By applying the progress made in geroscience (biology of aging) we identify and develop (up to POC) safe and well tolerated drugs that balance core biological processes associated with age-related functional decline.
Upcoming eventsAll events
Translational Research in CropsEvent by: VIB
EMDS2023@VIBEvent by: VIB
Latest newsMore news
HERAN Partners co-leads the GBP 6,5m financing round of Hypervision Surgical to support the further development and commercial roll-out of their Hyperspectral Imaging platform
Tuesday June 6th 2023
ANeuroTech receives IND approval from the FDA for pivotal Phase IIIB trial of adjunctive anti-depression drug, ANT-01
Monday June 5th 2023
Biotalys continues to demonstrate strength of first biocontrol in latest global field trials
Friday June 2nd 2023
Verantwoordelijke Moleculaire Microbiologie